IHS Chemical Week

EnviroTech :: R&D

Nicholas Piramal to Spin Off R&D Unit

11:42 AM MDT | September 14, 2007 | Deepti Ramesh

Pharmaceutical company Nicholas Piramal India Ltd. (NPIL; Mumbai) says it plans to demerge its R&D unit, creating a separate, independent company focused on developing novel drugs, otherwise known as new chemical entities (NCE). The demerger will be in the form of a spin-off to shareholders. NPIL will have an 18% stake in the new company, and NPIL’s shareholders will hold the rest. A proposal for the demerger has been approved by the NPIL board, and awaits regulatory and other approvals. NPIL will transfer net assets worth about $24 million to the new...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa